NRx Pharmaceuticals to Report Third Quarter 2022 Results on November 14, 2022

–Company to Host Conference Call November 14, 2022, at 8:00AM ET— RADNOR, Pa., Nov. 10, 2022 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage, biopharmaceutical company today announced that management will report third…

About the Author

has written 20655 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com